Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in patients with ulcerative colitis after treatment with infliximab.
Phase of Trial: Phase IV
Latest Information Update: 22 Dec 2015
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Biomarker; Therapeutic Use
- 22 Dec 2015 New trial record